Literature DB >> 16292791

Increased risk of complete congenital heart block in infants born to women with hypothyroidism and anti-Ro and/or anti-La antibodies.

Dawn Spence1, Lisa Hornberger, Robert Hamilton, Earl D Silverman.   

Abstract

OBJECTIVE: To determine whether the presence of hypothyroidism is associated with an increased incidence of neonatal lupus erythematosus (NLE) in infants of mothers with anti-Ro autoantibodies.
METHODS: The cohort consisted of 87 women with anti-Ro antibodies who delivered 102 infants. All infants had a full history and physical examination within 12 weeks of birth, electrocardiogram (echocardiogram when clinically indicated), complete blood cell count with differential, liver function tests, and autoantibody profile. Nine women had hypothyroidism and 78 had normal thyroid function.
RESULTS: At least one manifestation of NLE was seen in 7/9 (78%) infants born to mothers with hypothyroidism and 45/78 (58%) infants born to mothers with normal thyroid function. Complete congenital heart block (CCHB) was seen in 5/9 (55%) in the hypothyroid group and 10/78 (13%) of the normal thyroid function group (p < 0.005). Mothers with hypothyroidism had a 9-fold increased risk over women with normal thyroid function of having a child with CCHB (odds ratio 8.63). Twenty-seven (31%) of the women were healthy: 4/9 of the hypothyroid and 23/78 of the normal thyroid function group. Of the 23 infants born to healthy mothers with normal thyroid function, 15/23 (65%) had NLE and 8/23 (35%) of these had CCHB.
CONCLUSION: Women with hypothyroidism and anti-Ro antibodies were at increased risk for delivering a child with CCHB compared to women with antibodies alone, irrespective of maternal health. This study indicates that women with hypothyroidism should be tested for anti-Ro antibodies, as they may be at risk to deliver a child with CCHB.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16292791

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

Review 1.  Prenatal evaluation and management of fetuses exposed to Anti-SSA/Ro antibodies.

Authors:  Anita Krishnan; Jodi I Pike; Mary T Donofrio
Journal:  Pediatr Cardiol       Date:  2012-05-22       Impact factor: 1.655

2.  New aspects in the clinical spectrum of neonatal lupus.

Authors:  Rasa Laurinaviciene; Henrik Thybo Christesen; Anette Bygum
Journal:  Eur J Pediatr       Date:  2011-11-22       Impact factor: 3.183

Review 3.  The clinical spectrum of autoimmune congenital heart block.

Authors:  Pilar Brito-Zerón; Peter M Izmirly; Manuel Ramos-Casals; Jill P Buyon; Munther A Khamashta
Journal:  Nat Rev Rheumatol       Date:  2015-03-24       Impact factor: 20.543

Review 4.  Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.

Authors:  Antonio Brucato; Rolando Cimaz; Roberto Caporali; Véronique Ramoni; Jill Buyon
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 5.  Management of pregnancy in systemic lupus erythematosus.

Authors:  Aisha Lateef; Michelle Petri
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

6.  Neonatal lupus erythematosus.

Authors:  Kam Lun Hon; Alexander K C Leung
Journal:  Autoimmune Dis       Date:  2012-09-02

7.  Environmental and lifestyle factors influencing risk of congenital heart block during pregnancy in anti-Ro/SSA-positive women.

Authors:  Sabrina Meisgen; Joanna Tingström; Amanda Skog Andreasson; Sven-Erik Sonesson; Ingrid Kockum; Marie Wahren-Herlenius
Journal:  RMD Open       Date:  2017-09-07

8.  Fatal cardiac arrest in an adult patient with euthyroid anti-SSA/Ro-positive connective tissue disease: a case report.

Authors:  Michele Adami; Michele Nardin; Enrico Morello; Claudio Crivellaro; Christian J Wiedermann
Journal:  Int Arch Med       Date:  2009-05-15

9.  Resolution of neonatal hypertrophic cardiomyopathy presumed secondary to acquired maternal ribonucleoprotein and smith autoantibodies.

Authors:  A Shah; A Winrow; R Fulljames; N Naqvi; R A Bansal; A S Bansal
Journal:  AJP Rep       Date:  2013-05-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.